Leading London dental laboratory business sold in landmark deal

Leading London dental laboratory business sold in landmark deal
News

Image: Shutterstock

Specialist business property adviser, Christie & Co, has announced the sale of one of the UK’s leading dental laboratories, Ceramiart.

Established 27 years ago by Marcel Roetjens, Ceramiart Dental Laboratories is located in the heart of Marylebone in central London. The business, which is led by Marcel and his team of talented Dental Technicians, sits at the forefront of the digital transformation of dental technology, and works with many of the best practices across the UK.  

Following a sales process with Christie & Co, it has been sold to Dentex, which owns and operates 129 practices across the UK, a number of which already work with Ceramiart. Marcel will remain at the business going forward, working with Dentex to further develop and grow its offering.

Speaking about the sale, Marcel comments, “I am very proud to have helped grow Ceramiart into one of the leading laboratories in the dental sector. I am sure that Dentex will be an excellent partner and I look forward to working with them at this very exciting time in dentistry.”

On behalf of Dentex, CEO Barry Lanesman, comments, “Dentex is delighted to welcome Ceramiart to our group. As our first standalone fully specialised dental lab acquisition, we are excited to begin a partnership developing high-quality dental lab services. We look forward to working with Marcel and Ceramiart to grow the lab offering for our clinicians and the wider dental community.”

Simon Hughes, Managing Director – Medical at Christie & Co, who brokered the sale, comments, “Due to the first-class quality of the business and its strong profile in the profession, this really is a landmark deal for the sector. Ceramiart’s name is synonymous with the very best in dental technology, and we were delighted to work with Marcel and the Dentex team to complete the sale.”

Neha Shah from Capsticks solicitors acted for the seller, and Dentex was represented by its inhouse legal team.

Christie & Co

About Christie & Co

Head of Valuation – Medical Chris joined Christie & Co in 2008 and was appointed Director in 2010. Chris has overall responsibility for valuation work undertaken across our medical business with particular expertise in the GP, pharmacy and dental sectors. With a client base of leading corporate and independent operators together with key banks and lending institutions, Chris has been integrally involved in all of Christie & Co’s major medical advisory instructions since joining the business and is frequently invited to speak at industry events and conferences. Chris also attained his FRICS status in 2016 emphasising his expertise within the sector and industry.